Drug Detail:Arestin (mucous membrane powder) (Minocycline (mucous membrane powder) [ mye-no-sye-kleen ])
Drug Class: Mouth and throat products
Adult periodontitis:
1 mg applied subgingivally by an oral health care professional into the base of the affected periodontal pocket. The quantity of 1 mg unit dose packets required for treatment varies with the depth, severity, and number of lesions. During clinical trials, up to 121 unit dose containers of minocycline topical were applied to a single patient during a single treatment session. Additionally, patients were treated in up to 3 sessions occurring at 3 month intervals.
Data not available
Data not available
Data not available
Minocycline topical microspheres are approved as an adjunct to scaling and root planing procedures for reduction of pocket depth in patients with adult periodontitis.
Minocycline topical should be dispensed to and administered by an oral health care professional.
The use of minocycline topical microspheres in an acutely abscessed periodontal pocket has not been studied and is not recommended.
Use minocycline topical microspheres with caution in patients predisposed to oral candidiasis infections.
Because of the potential for tooth-staining, the use of minocycline topical microspheres in pediatric patients is not recommended.